Keywords: BPC-157, Body Protection Compound, pentadecapeptide, gastric peptide, tissue healing, tendon repair, gut healing, Sikiric, Zagreb research, growth factors, VEGF, angiogenesis, FAK-paxillin, nitric oxide, peptide research Frequently Asked Questions BPC-157 The following questions address the most common research, regulatory, dosing, and product queries about BPC-157
111 The drug did not alter superoxide dismutase, glutathione peroxidase, glutathione reductase, or glucose-6-phosphate dehydrogenase activity in the liver and heart
These can include redness or soreness at the injection site, which usually resolves within a few hours to days
Do not exceed